about
Emerging concepts in the immunopathogenesis of AIDSB7-H5 costimulates human T cells via CD28HAmbivalent role of the innate immune response in rabies virus pathogenesisTriggering receptor expressed on myeloid cell-like transcript 2 (TLT-2) is a counter-receptor for B7-H3 and enhances T cell responsesCTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanismsB7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survivalModulation of T-cell activation by malignant melanoma initiating cellsRole of PD-1 in HIV pathogenesis and as target for therapyProgrammed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancerImmune checkpoint inhibitors: the new frontier in non-small-cell lung cancer treatmentModulation of Innate Immune Mechanisms to Enhance Leishmania Vaccine-Induced Immunity: Role of Coinhibitory MoleculesThe Immunogenicity of Colorectal Cancer in Relation to Tumor Development and TreatmentImmune Checkpoint Modulators: An Emerging Antiglioma ArmamentariumSignaling in T cells - is anything the m(a)TOR with the picture(s)?Programmed cell death protein-1/programmed cell death ligand-1 pathway inhibition and predictive biomarkers: understanding transforming growth factor-beta roleLung cancer biomarkers, targeted therapies and clinical assaysImmune Checkpoint Modulation in Colorectal Cancer: What's New and What to ExpectCTLA-4 and PD-1 Pathways: Similarities, Differences, and Implications of Their InhibitionNarrowing the Gap: Preserving Repertoire Diversity Despite Clonal Selection during the CD4 T Cell ResponseUnderstanding the function and dysfunction of the immune system in lung cancer: the role of immune checkpointsStem cells and targeted approaches to melanoma cureMolecular mechanisms of T cell co-stimulation and co-inhibitionOptimal management of metastatic melanoma: current strategies and future directionsDendritic cell-based immunotherapy for glioma: multiple regimens and implications in clinical trialsImmunoregulatory molecules are master regulators of inflammation during the immune responseCheckpoint modulation--A new way to direct the immune system against renal cell carcinomaB7-H1 blockade increases survival of dysfunctional CD8(+) T cells and confers protection against Leishmania donovani infectionsBinding of superantigen toxins into the CD28 homodimer interface is essential for induction of cytokine genes that mediate lethal shockLiver-Infiltrating Lymphocytes in Chronic Human Hepatitis C Virus Infection Display an Exhausted Phenotype with High Levels of PD-1 and Low Levels of CD127 ExpressionUpregulation of PD-1 Expression on Circulating and Intrahepatic Hepatitis C Virus-Specific CD8+ T Cells Associated with Reversible Immune DysfunctionSynergistic Reversal of Intrahepatic HCV-Specific CD8 T Cell Exhaustion by Combined PD-1/CTLA-4 BlockadeFunctional Restoration of HCV-Specific CD8 T Cells by PD-1 Blockade Is Defined by PD-1 Expression and CompartmentalizationThe PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptorsCrystal structure of the complex between programmed death-1 (PD-1) and its ligand PD-L2Rigid-body Ligand Recognition Drives Cytotoxic T-lymphocyte Antigen 4 (CTLA-4) Receptor TriggeringA dimeric structure of PD-L1: functional units or evolutionary relics?The Molecular Basis for Modulation of Human V 9V 2 T Cell Responses by CD277/Butyrophilin-3 (BTN3A)-specific AntibodiesThe blockade of immune checkpoints in cancer immunotherapyRecent advances in understanding antitumor immunityTrends and advances in tumor immunology and lung cancer immunotherapy
P2860
Q22241984-97AD24D0-2AF7-4FBF-B4CF-DB23D7FB5574Q24295841-B099CBD8-A608-42AA-84DE-AB6FE9AB8642Q24300579-959D2AD3-A05C-4A5E-A7FD-B3B3E55DE824Q24316331-1B92B969-EA31-4BC0-99D6-173D2409C376Q24534904-A570B4D8-D808-4B75-ABFD-BED453B5585FQ24550945-83B359E8-D6C8-4E8C-9C5F-AD19053304D2Q24595394-C4EDFE49-B2EE-4121-A40D-14E818C9C237Q24634293-5B782462-9DD2-4DC3-900D-5D7EAA867BC0Q24685406-DCF1C700-9957-4446-AA7D-29BB92678A1FQ26738359-06FA8F34-838C-4A55-BCC3-D1516ED02480Q26744635-F6A22E33-543E-4215-9B3E-424BD30EA73DQ26745580-D51CE02F-DF58-4BAF-9A61-8B42B79075B9Q26765459-58FFCCC2-8111-49A0-AAD3-B89C0FDE7488Q26767443-D50AB9DB-88FD-426D-AABD-48BEA2026204Q26769734-9007131B-D612-4DD1-A0EE-85716B30D037Q26775396-415AEED1-5623-4465-97EF-6AF0BD6632A3Q26775578-28CDE744-9868-46A4-ABCF-3F19F8DCDABEQ26777563-A2246C87-91F0-49A0-A344-F713AD1B67B1Q26796086-E8FAA49C-958B-4D43-B556-2EBB61E499FDQ26801551-5D23CE12-35C9-4A75-BFC9-38F00CBAA5B3Q26825014-A62B2CFD-1FB1-4F27-9C2D-414E52107423Q26864888-F7930641-E44A-4CBD-A29B-F26B286C154EQ26997338-8097EE79-8338-4556-8DE9-93FBA8FFE631Q27014829-1EBFD087-B6A3-40CE-A65A-CA8273A04330Q27022027-5E5A5DA8-2E7B-4279-A8CD-BA08D82FD104Q27025873-2D2199AC-CD85-45D1-8A9F-3FFE54BF964BQ27317015-862206C3-2986-4485-8739-B3C6F561B2F7Q27321007-392BB654-EEF5-43D8-AB0B-A443E57AB8FFQ27478366-8E41FB34-E7F4-4FB4-A446-0A84420B74DEQ27481027-0A13126E-C4EE-44DD-826B-130F033D26E0Q27487939-4441C8BC-1E3F-45D9-AB17-E72B795DAB10Q27488289-7AC41AF9-3795-47B1-B1FD-DE6C080DF62BQ27649885-D5DE1BD7-F122-474C-A24C-A42C46162515Q27651269-D6C19463-0FAE-4E9E-BF50-FD7C441AA196Q27666303-5B080082-CED8-4DBA-B3AC-07DCE81955A7Q27666463-3A98EB13-356E-4659-A0D1-AA8F0678C2FCQ27670973-0B90F9A0-390D-45C1-914E-4F75EDEE1779Q27860852-57531047-72D7-4F6D-B63E-A2BF9EC69786Q28067217-AF7F6DF1-583C-4334-8E23-8F3DD747FBB0Q28067674-3030C23F-95AA-4671-B60A-6A60BA5BBD92
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականին հրատարակուած գիտական յօդուած
@hyw
2005 թվականին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
The B7 family revisited
@ast
The B7 family revisited
@en
The B7 family revisited
@nl
type
label
The B7 family revisited
@ast
The B7 family revisited
@en
The B7 family revisited
@nl
prefLabel
The B7 family revisited
@ast
The B7 family revisited
@en
The B7 family revisited
@nl
P2093
P3181
P1476
The B7 family revisited
@en
P2093
Arlene H Sharpe
Gordon J Freeman
Rebecca J Greenwald
P304
P3181
P356
10.1146/ANNUREV.IMMUNOL.23.021704.115611
P407
P577
2005-01-01T00:00:00Z